These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10641821)

  • 21. Cardiovascular diseases and risk factors in Finland.
    Vartiainen E; Puska P; Jousilahti P; Korhonen HJ
    Prev Med; 1999 Dec; 29(6 Pt 2):S124-9. PubMed ID: 10641830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of targeted intervention on the incidence of risk factors of cardiovascular diseases at medical staff].
    Sovová E; Nakládalová M; Kaletová M; Lukl J; Benusová I; Doupalová P
    Vnitr Lek; 2006 Jan; 52(1):21-5. PubMed ID: 16526194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing cardiovascular disease in women.
    Hayes SN
    Am Fam Physician; 2006 Oct; 74(8):1331-40. PubMed ID: 17087427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study.
    Rodriguez BL; Fujimoto WY; Mayer-Davis EJ; Imperatore G; Williams DE; Bell RA; Wadwa RP; Palla SL; Liu LL; Kershnar A; Daniels SR; Linder B
    Diabetes Care; 2006 Aug; 29(8):1891-6. PubMed ID: 16873798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal management of hyperlipidemia in primary prevention of cardiovascular disease.
    Raza JA; Babb JD; Movahed A
    Int J Cardiol; 2004 Dec; 97(3):355-66. PubMed ID: 15561319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different outcomes for different interventions with different focus!--A cross-country comparison of community interventions in rural Swedish and US populations.
    Weinehall L; Lewis C; Nafziger AN; Jenkins PL; Erb TA; Pearson TA; Wall S
    Scand J Public Health Suppl; 2001; 56():46-58. PubMed ID: 11681563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
    Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
    Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of socioeconomic factors on cardiovascular disease risk factor development.
    Tyroler HA
    Prev Med; 1999 Dec; 29(6 Pt 2):S36-40. PubMed ID: 10641816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular disease in Chinese women: an emerging high-risk population and implications for nursing practice.
    Cao Y; DiGiacomo M; Du HY; Ollerton E; Davidson P
    J Cardiovasc Nurs; 2008; 23(5):386-94; quiz 395-6. PubMed ID: 18728510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individuals' cardiovascular risk profile projected by family doctors and individuals' knowledge of cardiovascular risk factors: a challenge for primary prevention. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Celentano A; Palmieri V; Panico S; Russo C; Arezzi E; Pezzullo S; Minichiello S; Guillaro B; Brancati C; Piccinocchi G; Di Minno G
    Ital Heart J; 2005 Jul; 6(7):557-64. PubMed ID: 16274017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of multidisciplinary patient counselling in reducing cardiovascular disease risk factors through nonpharmacological intervention: results from the Healthy Heart Program.
    Simpson DR; Dixon BG; Bolli P;
    Can J Cardiol; 2004 Feb; 20(2):177-86. PubMed ID: 15010741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial.
    Langham J; Tucker H; Sloan D; Pettifer J; Thom S; Hemingway H
    Br J Gen Pract; 2002 Oct; 52(483):818-24. PubMed ID: 12392122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelium summary statement II: Cardiovascular disease prevention and control.
    Mensah GA; Ryan US; Hooper WC; Engelgau MM; Callow AD; Kapuku GK; Mantovani A
    Vascul Pharmacol; 2007 May; 46(5):318-20. PubMed ID: 17229595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin overprescription in primary cardiovascular prevention.
    Manes C; Giacci L; Sciartilli A; D'Alleva A; De Caterina R
    Thromb Res; 2006; 118(4):471-7. PubMed ID: 16321425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of risk for cardiovascular disease during school-age/adolescent transition.
    Pittman KP; Hayman LL
    Prog Cardiovasc Nurs; 1997; 12(4):12-22. PubMed ID: 9433729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventions for cardiovascular disease prevention.
    Gupta R; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):15-34. PubMed ID: 21257098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.